Role of Group A streptococcus (GAS) M6 class 1 epitope in antiphospholipid syndrome by Manning, Morenci Marie
ABSTRACT 
Thesis:  Role of Group A Streptococcus (GAS) M6 Class 1 Epitope in Antiphospholipid 
Syndrome 
Student: Morenci Manning 
Degree: Master of Science  
College: Biology  
Date: December 2015 
Pages: 26 
Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by thrombosis, 
recurrent fetal loss, and the presence of pathogenic levels of antiphospholipid antibodies (aPL). 
APS has been shown to develop as a result of an overly-stimulated immune system. This 
commonly results from infection but the exact etiology remains unknown. Rheumatic Fever 
(RF)/Rheumatic Heart Disease (RHD) are an autoimmune consecution of higher lethality than 
APS. RF/RHD shares multiple secondary disease manifestations, alluding to a common 
pathogenesis and significant levels of streptococcal antibodies have been found in APS patients. 
Group A Streptococcus is a bacterial strain belonging to the Streptococcus pyogenes family. It 
has an established role in the autoimmunity observed in RF/RHD. The M protein of GAS in 
particular, demonstrates structural homology to vital host structures thereby facilitating 
molecular mimicry. It has not previously been shown whether GAS M protein is sufficient to 
induce APS. The aim of this study was to determine whether injection of the M6 protein epitope, 
10F5, is sufficient to induce the production of antiphospholipid antibodies. Methods Lewis Rats 
were divided into groups, Experimental (EX, n=6), Experimental Control (EC, n=6), and 
Negative Control (NC, n=4). Animals were bled at time point 0, weeks 4, 6, and 8. Additionally, 
EX and EC groups received injections of peptide with adjuvant and water with adjuvant 
respectively at day 1 and 4 weeks post initial injection. The NC group was not injected. ELISA 
was performed on the serum collected at each time point and the concentration of aPL quantified. 
Results There was a significant difference in the serum concentration of aPL between the NC 
and the EX groups (p < 0.00003). From T2-T4 there was a72% decrease in serum aPL in the NC 
group, a 12% increase in the EC group and a 16% increase in the EX group. Conclusion 
Injection of Class 1 Epitope is sufficient to produce antiphospholipid antibodies and therefore 
induce the marker for Antiphospholipid Syndrome in Lewis Rats. However, further studies are 
needed in order to establish a clearer connection between the aPL produced and induction of the 
actual disease.  
  
 
